Cell-mediated immunity in patients with basal and squamous cell skin cancer - 06/10/17
Résumé |
T and B lymphocyte levels were normal in fifty patients with basal and squamous cell skin cancer. Patients with basal cell carcinomas and small squamous cell carcinomas reacted normally to intradermal antigens and to dinitrochlorobenzene (DNCB). However, patients with large (>3 cm) squamous cell carcinomas appeared to have defective systemic cell-mediated immunity because only 33% of them reacted to at least one intradermal antigen, and only 67% could be sensitized to DNCB. Presently, it is unknown whether this defect is related to the occurrence or behavior of squamous cell carcinoma.
Le texte complet de cet article est disponible en PDF.| Supported in part by a grant from the National Cancer Institute (I R25 CA 18017-04) and a grant from the Biomedical Research Support Branch, Division of Research Facilities and Resources, National Institutes of Health (RR 05372). |
|
| Presented in part at the meeting of the American Academy of Dermatology, Chicago, IL, Dec. 4, 1979. |
Vol 2 - N° 2
P. 143-147 - février 1980 Retour au numéro
Article précédent
- The abnormal dermis in pyogenic granuloma : Histochemical and ultrastructural observations
- Michael Glanmor Davies, Stephen Peter Barton, Farideh Atai, Ronald Marks
- Chondrodermatitis nodularis chronica helicis: A perforating necrobiotic granuloma
- Detlef K. Goette
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?